Elevated homocysteine and differential risks of the renal function decline in hypertensive patients

References

• Wang JG.Chinese hypertension guidelines. Pulse (Basel). 2015;3(1):14–20. doi:10.1159/000382025.
   PubMedGoogle Scholar
• Khera R, Lu Y, Lu J, Saxena A, Nasir K, Jiang L, Krumholz HM. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. BMJ. 2018;362:k2357.
   PubMed Web of Science ®Google Scholar
• EYF W, EYT Y, Chin WY, Fong DYT, Choi EPH, Tang EHM, Lam CLK. Burden of CKD and cardiovascular disease on life expectancy and health service utilization: a cohort study of Hong Kong Chinese hypertensive patients. J Am Soc Nephrol. 2019;30(10):1991–99. doi:10.1681/ASN.2018101037.
   PubMed Web of Science ®Google Scholar
• Kozłowski L, Kozłowska K, Małyszko J.Hypertension and chronic kidney disease is highly prevalent in elderly patients with colorectal cancer undergoing primary surgery. Adv Clin Exp Med. 2019;28(10):1425–28. doi:10.17219/acem/104537.
   PubMed Web of Science ®Google Scholar
• Verdalles U, Goicoechea M, de Vinuesa SG, Torres E, Hernández A, Verde E, Pérez de José A, Luño J. Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: intensification with loop diuretics vs aldosterone antagonists. Nefrologia. 2020;40(1): 65-73.
   PubMed Web of Science ®Google Scholar
• Oliveras A.Prognostic value of adiposity indices for hypertension. J Clin Hypertens (Greenwich). 2019;21(10):1505–06. doi:10.1111/jch.13668.
   PubMed Web of Science ®Google Scholar
• Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, et al. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017;28(9):2812–23. doi:10.1681/ASN.2017020148.
   PubMed Web of Science ®Google Scholar
• Anniwaer J, Liu MZ, Xue KD, Maimaiti A, Xiamixiding A.Homocysteine might increase the risk of recurrence in patients presenting with primary cerebral infarction. Int J Neurosci. 2019;129(7):654–59. doi:10.1080/00207454.2018.1517762.
   PubMed Web of Science ®Google Scholar
• Diwaker A, Kishore D. Evaluation of plasma homocysteine levels in patients of PCOS. J Assoc Physicians India. 2018;66(10):17–20.
   PubMedGoogle Scholar
• Kolyvanos NU, Suter PM, Käser L, Vetter W.[Homocysteinemia]. Praxis (Bern 1994). 2005;94(34):1289–93; quiz 1294. doi:10.1024/0369-8394.94.34.1289.
   Google Scholar
• Kong X, Ma X, Zhang C, Su H, Xu D.Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort. Int Urol Nephrol. 2017;49(4):661–67. doi:10.1007/s11255-016-1452-3.
   PubMed Web of Science ®Google Scholar
• Xie D, Yuan Y, Guo J, Yang S, Xu X, Wang Q, Li Y, Qin X, Tang G, Huo Y, et al. Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults. Sci Rep. 2015;5(1):16268. doi:10.1038/srep16268.
   PubMed Web of Science ®Google Scholar
• Hua Q, Fan L, Li J.Chinese guideline for the management of hypertension in the elderly. J Geriatr Cardiol. 2019;16(2):67–99. doi:10.11909/j..1671-5411.2019.02.001.
   PubMedGoogle Scholar
• Veeranna V, Zalawadiya SK, Niraj A, Pradhan J, Ference B, Burack RC, Jacob S, Afonso L. Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol. 2011;58(10):1025–33. doi:10.1016/j.jacc.2011.05.028.
   PubMed Web of Science ®Google Scholar
• Zhang W.Cardiovascular risk stratification in Chinese patients with hypertension. J Clin Hypertens (Greenwich). 2019;21(10):1607–08. doi:10.1111/jch.13680.
   PubMed Web of Science ®Google Scholar
• Zdrojewski Ł, Zdrojewski T, Rutkowski M, Bandosz P, Król E, Wyrzykowski B, Rutkowski B. Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey. Nephrol Dial Transplant. 2016;31(3):433–39. doi:10.1093/ndt/gfv369.
   PubMed Web of Science ®Google Scholar
• Cui ZT, Liu JP, Yao JM.Antagonistic effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenovirus on homocysteine-induced vascular endothelial cells injury in vitro and in vivo. Medicine (Baltimore). 2016;95(44):e5197. doi:10.1097/MD.0000000000005197.
   PubMed Web of Science ®Google Scholar
• Cohen E, Margalit I, Shochat T, Goldberg E, Krause I.The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort. J Nephrol. 2019;32(5):783–89. doi:10.1007/s40620-019-00618-x.
   PubMed Web of Science ®Google Scholar
• Manani R, Kazemzadeh G, Saberi A, Sadeghipour F, Rahmani A.Effect of local papaverine on arteriovenous fistula maturation in patients with end-stage renal disease. J Bras Nefrol. 2019;41(2):185–92. doi:10.1590/2175-8239-jbn-2018-0170.
   PubMedGoogle Scholar
• Zang T, Pottenplackel LP, Handy DE, Loscalzo J, Dai S, Deth R, Zhou Z, Ma J. Comparison of protein N-homocysteinylation in rat plasma under elevated homocysteine using a specific chemical labeling method. Molecules. 2016;21(9):1195. doi:10.3390/molecules21091195.
   Web of Science ®Google Scholar
• Saito M, Marumo K.The effects of homocysteine on the skeleton. Curr Osteoporos Rep. 2018;16(5):554–60. doi:10.1007/s11914-018-0469-1.
   PubMed Web of Science ®Google Scholar
• Oliveira SR, Flauzino T, Sabino BS, Kallaur AP, Alfieri DF, Kaimen-Maciel DR, Morimoto HK, de Almeida ERD, Lozovoy MAB, Reiche EMV, et al. Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis. Metab Brain Dis. 2018;33(5):1393–99. doi:10.1007/s11011-018-0224-4.
   PubMed Web of Science ®Google Scholar
• Shirafuji N, Hamano T, Yen SH, Kanaan N, Yoshida H, Hayashi K, Ikawa M, Yamamura O, Kuriyama M, Nakamoto Y, et al. Homocysteine increases tau phosphorylation, truncation and oligomerization. Int J Mol Sci. 2018;19(3):891. doi:10.3390/ijms19030891.
   Web of Science ®Google Scholar
• Momoniat T, Ilyas D, Bhandari S.ACE inhibitors and ARBs: managing potassium and renal function. Cleve Clin J Med. 2019;86(9):601–07. doi:10.3949/ccjm.86a.18024.
   PubMed Web of Science ®Google Scholar
• Gaifullina AS, Lazniewska J, Gerasimova EV, Burkhanova GF, Rzhepetskyy Y, Tomin A, Rivas-Ramirez P, Huang J, Cmarko L, Zamponi GW, et al. A potential role for T-type calcium channels in homocysteinemia-induced peripheral neuropathy. Pain. 2019;160(12):2798–810. doi:10.1097/j.pain.0000000000001669.
   PubMed Web of Science ®Google Scholar